ライフサイエンスコーパス: adipose tissue mass

1 k loop that maintains homeostatic control of adipose tissue mass.

2 This system maintains homeostatic control of adipose tissue mass.

3 esity, as reflected by a marked reduction in adipose tissue mass.

4 major regulators of APC differentiation and adipose tissue mass.

5 en specifically linked to increased visceral adipose tissue mass.

6 or normal development and for homeostasis of adipose tissue mass.

7 ulin:glucagon ratio in the serum and reduced adipose tissue mass.

8 produced by adipose tissue in proportion to adipose tissue mass.

9 onance imaging shows a striking reduction in adipose tissue mass.

10 class of genes involved in the regulation of adipose tissue mass.

11 mount of intraperitoneal and retroperitoneal adipose tissue mass.

12 iated with a lean phenotype and reduced body adipose tissue mass.

13 reases serum cholesterol, triglycerides, and adipose tissue mass.

14 retardation and reduced skeletal muscle and adipose tissue masses.

15 ect of empagliflozin on bioimpedance-derived adipose tissue mass (-0.28 kg [95% CI, -1.41 to 0.85]).

16 bFKB1 lowered body weight (-21%) and adipose tissue mass (-22%) without reducing food intake.

17 ce obese individuals seem to have less brown adipose tissue mass/activity than do their lean counterp

18 and leads to a large, specific reduction of adipose tissue mass after several days.

19 r program responsible for the restoration of adipose tissue mass after weight loss is largely unchara

20 Decreasing adipose tissue mass alone will not achieve the metabolic

21 ese mice fed the HFD reduced body weight and adipose tissue mass, ameliorated hepatic steatosis assoc

22 All three mutants showed increased white adipose tissue mass and adipocyte size.

23 Chronic alcohol exposure reduced adipose tissue mass and adipocyte size.

24 Adipose tissue mass and adiposity change throughout the

25 reduced GIP receptor (GIPR) signaling reduce adipose tissue mass and attenuate weight gain in respons

26 ight, mainly because of an increase in white adipose tissue mass and BAT whitening.

27 Hepatic deletion of PC-TP also reduced adipose tissue mass and decreases levels of triglyceride

28 cose, and FFAs during a euglycemic clamp and adipose tissue mass and distribution, organ fat, and adi

29 one secreted by adipose tissue and regulates adipose tissue mass and energy balance.

30 deletion decreased the size of the visceral adipose tissue mass and enhanced insulin sensitivity in

31 ion of body weight and liver and brown/white adipose tissue mass and function and normalization of ph

32 t the Sra1 gene is an important regulator of adipose tissue mass and function.

33 ed insulin secretion, decreased expansion of adipose tissue mass and preservation of insulin sensitiv

34 ytes, Ucp1-STX4KO mice display loss of brown adipose tissue mass and thermogenic dysfunction concomit

35 AdPLA-null mice have markedly reduced adipose tissue mass and triglyceride content but normal

36 1 in fat displayed reduced lipid storage and adipose tissue mass and were resistant to diet-induced o

37 However, changes in overall weight (adipose tissue mass) and hepatic fat were the most impor

38 offspring metabolic health included growth, adipose tissue mass, and 12-week glucose and insulin con

39 splayed significantly increased body weight, adipose tissue mass, and adipocyte cell size and reduced

40 sulin challenge, decreased thermogenic brown adipose tissue mass, and exaggerated hepatic endocannabi

41 999A mice exhibited low body weight, reduced adipose tissue mass, and increased lifespan, similar to

42 eptin mRNA levels are highly correlated with adipose tissue mass, and leptin expression can thus be u

43 at mass, total adipose tissue mass, visceral adipose tissue mass, and superficial adipose tissue mass

44 administration to obese mice did not reduce adipose tissue mass, and the compensatory increase in GS

45 ulin receptor knock-out (FIRKO) have reduced adipose tissue mass, are protected against obesity, and

46 atic TG even though they lost nearly as much adipose tissue mass as the C57BL/6J mice.

47 eased body weight, adipocyte size, and white adipose tissue mass, as assessed by magnetic resonance i

48 GHa mice exhibit a twofold increase in white adipose tissue mass, as well as increased levels of seru

49 The increase of adipose tissue mass associated with obesity is due in pa

50 ormone that maintains homeostatic control of adipose tissue mass by regulating the activity of specif

51 An increase in adipose tissue mass can be the result of the production

52 he hypothesis that the posterior left atrial adipose tissue mass contributes to structural and electr

53 specific body-weight set point and defended adipose tissue mass converging with an obesogenic enviro

54 d weight gain are characterized by increased adipose tissue mass due to an increase in the size of in

55 o directly contribute to a failure to expand adipose tissue mass during states of excess caloric inta

56 Iron supplemented mice had lower visceral adipose tissue mass estimated by epididymal fat pad, ass

57 isceral adipose tissue mass, and superficial adipose tissue mass (for all interactions, P < 0.05).

58 tin are essential for homeostatic control of adipose tissue mass, glucose metabolism, and many autono

59 Indomethacin had no effect on adipose tissue mass, glucose tolerance, or GSIS when inc

60 Treatment with an FTI increased adipose tissue mass, improved body weight curves, reduce

61 ogenesis and its possible role in regulating adipose tissue mass in adults can now be tested.

62 potential of GPAT inhibitors to rescue white adipose tissue mass in CGL2.

63 Consistent with the observed reduction of adipose tissue mass in fld and fld(2J)mice, wild-type Lp

64 a levels of leptin correlate positively with adipose tissue mass in normal humans and animals, recent

65 products result in significant reductions in adipose tissue mass in obese humans in the absence of ca

66 mice consume equal amounts of food, but the adipose tissue mass in the null animals is reduced to ap

67 Furthermore, HDL decreases white adipose tissue mass, increases energy expenditure, and p

68 Adipose tissue mass is determined by both the number and

69 White adipose tissue mass is governed by competing processes t

70 We conclude that adipose tissue mass is sensitive to angiogenesis inhibit

71 Posterior left atrial adipose tissue mass is significantly larger in patients

72 Obesity, defined as an increase in adipose tissue mass, is the most prevalent nutritional d

73 Enlargement of adipose tissue mass leads to an appropriate downregulati

74 indings describe a further mechanism whereby adipose tissue mass may be modified by TNF-alpha.

75 have been identified, but the modulation of adipose tissue mass may have both advantageous and delet

76 sed abdominal adiposity in males only (white adipose tissue mass (mg): CON 280.5 +/- 13.4 [mean +/- S

77 to be natural bioactive factors effective in adipose tissue mass modulation.

78 trophy syndromes are conditions in which the adipose tissue mass of an individual is altered inapprop

79 us, treatable with interventions that reduce adipose tissue mass or improve adipocyte biology.

80 ave the ability to expand their subcutaneous adipose tissue mass, particularly in the gluteal-femoral

81 dy was to assess whether an increased atrial adipose tissue mass posterior to the left atrium is rela

82 Decreases in weight and adipose tissue mass predicted improvements in GDR but no

83 rs, which are effective in the inhibition of adipose tissue mass production.

84 targeted knock-out of Nrf2 in mice decreases adipose tissue mass, promotes formation of small adipocy

85 Thus, ApoL6 ablation decreases white adipose tissue mass, protecting mice from diet-induced o

86 other-while nonresponders increased visceral adipose tissue mass, responders increased adipose tissue

87 ole-body fat mass was not affected, visceral adipose tissue mass tended to decrease after the interve

88 ls of chimerism showed a significantly lower adipose tissue mass than animals with high levels of chi

89 ese men had substantially (2.5-fold) greater adipose tissue mass than lean control subjects, but the

90 er is a major contributor to the increase in adipose tissue mass that is characteristic of obesity.

91 sia accounts for the severalfold increase in adipose tissue mass that occurs throughout life, yet the

92 ty is characterized by an expansion of white adipose tissue mass that results from an increase in the

93 ted by adipocytes, regulates the size of the adipose tissue mass through effects on satiety and energ

94 responds by adjusting food intake to restore adipose tissue mass to a regulated level.

95 Furthermore, the addition of the adipose tissue mass to the multiple variable analysis si

96 Excessive adipose tissue mass underlies much of the metabolic heal

97 ole body total percentage of fat mass, total adipose tissue mass, visceral adipose tissue mass, and s

98 The difference in adipose tissue mass was attributed to variability in the

99 The posterior left atrial adipose tissue mass was quantified on computed tomograph

100 In the IF offspring, adipose tissue mass was significantly increased.

101 The adipose tissue mass was significantly larger in patients

102 eptin release by leg tissue, relative to leg adipose tissue mass, was comparable with that reported p

103 tolerance, insulin resistance, and increased adipose tissue mass were observed in animals harboring a

104 Body weight gain and adipose tissue mass were significantly reduced by soy bu

105 (-/-) animals showed reduced body weight and adipose tissue mass with a significant decrease of the e

106 t Bif-1 deficiency promotes the expansion of adipose tissue mass without altering food intake or phys

107 es in terms of a deficiency versus excess of adipose tissue mass, yet these conditions are accompanie